medigraphic.com
ISSN 2395-8723 (Electronic)
ISSN 1405-888X (Print)
TIP Revista Especializada en Ciencias Químico-Biológicas

2021, Number 1

<< Back Next >>

TIP Rev Esp Cienc Quim Biol 2021; 24 (1)

In vitro and in silico biological evaluation of phthalimide derivatives as antiproliferative agents

Sierra-Rivera CA, Kashif M, Vázquez-Jiménez LK, Zugasti-Cruz A, Juárez-Saldivar A, Paz-González AD, Rivera G

Language: English
References: 35
Page:
PDF size: 985.86 Kb.


ABSTRACT

Phthalimide is considered a scaffold for the development of new anticancer agents. In this work, the antiproliferative activity of forty-three phthalimide derivatives was evaluated against cervical (HeLa), liver (HepG2), breast (4T1) cancer cell lines, and a normal cell line of murine fibroblasts (3T3). Finally, a molecular docking analysis of phthalimide derivatives on the active site of the enzymes DNA methyltransferase 1 (DNMT1) and vascular endothelial growth factor receptor 2 (VEGR2) as potential drug targets was performed. The compounds, C16, E11, and E16 showed the best antiproliferative activity against the cell lines HeLa and 4T1. Only, the compound H16 decreased 32% cell proliferation against HepG2 cell line. The compounds H5, H16, E2, E16, and C1 did not affect the proliferation of the 3T3 cell line. The molecular docking analysis showed that phthalimide derivatives have a greater affinity for DNMT1 than S-adenosyl-l-homocysteine, a potent DNMT1 inhibitor. However, molecular docking results do not correlate with their antiproliferative effects, suggesting another potential mechanism of action for the active compounds.


REFERENCES

  1. Abdelhaleem, E. F., Abdelhameid, M. K., Kassab, A. E. & Kandeel, M. M. (2018). Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7. European Journal of Medicinal Chemistry, 143, 1807-1825. https://doi.org/10.1016/j.ejmech.2017.10.075

  2. Al-Abbasi, F. A., Alghamdi, E. A., Baghdadi, M. A., Alamoudi, A. J., El-Halawany, A. M., El-Bassossy, H. M., Aseeri, A. H. & Al-Abd, A. M. (2016). Gingerol Synergizes the Cytotoxic Effects of Doxorubicin against Liver Cancer Cells and Protects from Its Vascular Toxicity. Molecules, 21(7), 886. https://doi.org/10.3390/molecules21070886

  3. Aliabadi, A., Mohammadi-Farani, A., Hosseinzadeh, Z., Nadri, H., Moradi, A. & Ahmadi, F. (2015). Phthalimide analogs as probable 15-lipoxygenase-1 inhibitors: synthesis, biological evaluation and docking studies. Daru Journal of Pharmaceutical Sciences, 23(1), 36. https://doi. org/10.1186/s40199-015-0118-5

  4. Al-Soud, Y. A. & Al-Masoudi, N. A. (2001). Synthesis and antitumor activity of some new phthalimide analogues. Pharmazie, 56, 372-375. https://doi.org/10.1002/ CHIN.200132132

  5. Asgatay, S., Champion, C., Marloie, G., Drujon, T., Senamaud- Beaufort, C., Ceccaldi, A., Erdmann, A., Rajavelu, A., Schambel, P., Jeltsch, A., Lequin, O., Karoyan, P., Arimondo, P. B. & Guianvarc’h, D. (2014). Synthesis and evaluation of analogues of N-phthaloyl-L-tryptophan (RG108) as inhibitors of DNA methyltransferase 1. Journal of Medicinal Chemistry, 57, 421-434. https://doi.org/10.1021/jm401419p

  6. Bailly, C., Carrasco, C., Joubert, A., Bal, C., Wattez, N., Hildebrand, M.P., Lansiaux, A., Colson, P., Houssier, C., Cacho, M., Ramos, A. & Braña, M.F. (2003). Chromophore-modified bisnaphthalimides: DNA recognition, topoisomerase inhibition, and cytotoxic properties of two mono-and bisfuronaphthalimides. Biochemistry, 42, 4136-4150. https://doi.org/10.1021/ bi027415c

  7. Chen, Z., Liang, X., Zhang, H., Xie, H., Liu, J., Xu, Y., Zhu, W., Wang, Y., Wang, X., Tan, S., Kuang, D. & Qian, X. (2010). A new class of naphthalimide-based anti-tumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis. Journal of Medicinal Chemistry, 53, 2589-2600. https://doi. org/10.1021/jm100025u

  8. Grigalius, I. & Petrikaite, V. (2017). Relationship between Antioxidant and Anticancer Activity of Trihydroxyflavones. Molecules, 22, 2169. https://doi.org/10.3390/ molecules22122169

  9. Kamal, A., Reddy, B. S. N., Reddy, G. S. K. & Ramesh, G. (2002). Design and synthesis of C-8 linked pyrrolobenzodiazepinenaphthalimide hybrids as anti-tumour agents. Bioorganic and Medicinal Chemistry Letters, 12, 1933-1935. https:// doi.org/10.1016/S0960-894X(02)00326-8

  10. Kamal, A., Bolla, N. R., Srikanth, P. S. & Srivastava, A. K. (2013). Naphthalimide derivatives with therapeutic characteristics: a patent review. Expert Opinion on Therapeutic Patents, 23, 299-317. https://doi.org/10.1517/13543776.2013.746313

  11. Kashif, M., Chacón-Vargas, K. F., López-Cedillo, J. C., Nogueda-Torres, B., Paz-González, A. D., Ramírez- Moreno, E., Agusti, R., Uhrig, M. L., Reyes-Arellano, A., Peralta-Cruz, J., Ashfaq, M. & Rivera, G. (2018). Synthesis, molecular docking and biological evaluation of novel phthaloyl derivatives of 3-amino-3-aryl propionic acids as inhibitors of Trypanosoma cruzi trans-sialidase. European Journal of Medicinal Chemistry, 156, 252-268. https://doi. org/10.1016/j.ejmech.2018.07.005

  12. Kilic-Kurt, Z., Bakar-Ates, F., Karakas, B. & Kütük, Ö. (2018). Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d] Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines. Anticancer Agents in Medicinal Chemistry, 18, 1303-1312. https://doi.org/10.2174/1871520618666 180605082026

  13. Li, X., Lin, Y., Wang, Q., Yuan, Y., Zhang, H. & Qian, X. (2011). The novel anti-tumor agents of 4-triazol-1, 8- naphthalimides: synthesis, cytotoxicity, DNA intercalation and photocleavage. European Journal of Medicinal Chemistry, 46, 1274-1279. https://doi.org/10.1016/j. ejmech.2011.01.050

  14. Lu, G. Q., Li, X.Y., Mohamed, O. K., Wang, D. & Meng, F. H. (2019). Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs. European Journal of Medicinal Chemistry, 171, 282-296. https://doi.org/10.1016/j. ejmech.2019.03.047

  15. Mai, A. & Altucci, L. (2009). Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. International Journal of Biochemistry & Cell Biology, 41, 199-213. https://doi.org/10.1016/j.biocel.2008.08.020

  16. Matsuo, K. Lin, Y. G., Roman, L. D. & Sood A. K. (2010). Overcoming platinum resistance in ovarian carcinoma. Expert Opinion on Investigational Drugs, 19, 1339-54. https://doi.org/10.1517/13543784.2010.515585

  17. Miyachi, H., Ogasawara, A., Azuma, A. & Hashimoto, Y. (1997). Tumor necrosis factor-alpha production-inhibiting activity of phthalimide analogues on human leukemia THP-1 cells and a structure-activity relationship study. Bioorganic & Medicinal Chemistry, 5, 2095-2102. https:// doi.org/10.1016/S0968-0896(97)00148-X

  18. Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S. & Olson A. J. (2009). Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry, 16, 2785-2791. https://doi.org/10.1002/jcc.21256

  19. O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T. & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3, 33. https://doi.org/10.1186/1758-2946-3-33

  20. Olazarán-Santibáñez, F., Bandyopadhyay, D., Carranza- Rosales, P., Rivera, G. & Balderas-Rentería, I. (2017a). Stereochemical preference toward oncotarget: Design, synthesis and in vitro anticancer evaluation of diastereomeric β-lactams. Oncotarget, 8, 37773-37782. https://doi. org/10.18632/oncotarget.18077

  21. Olazarán, F. E., Rivera, G., Pérez-Vázquez, A. M., Morales- Reyes, C.M., Segura-Cabrera, A. & Balderas-Rentería, I. (2017b). Biological Evaluation in vitro and in silico of Azetidin-2-one Derivatives as Potential Anticancer Agents. ACS Medicinal Chemistry Letters, 8, 32-37. https://doi. org/10.1021/acsmedchemlett.6b00313

  22. Othman, I. M. M., Gad-Elkareem, M. A. M., El-Naggar, M., Nossier, E. S. & Amr, A. E. E. (2019). Novel phthalimide based analogues: design, synthesis, biological evaluation, and molecular docking studies. Journal of Enzyme Inhibition and Medicinal Chemistry, 34(1), 1259-1270. https://doi. org/10.1016/j.bioorg.2019.102978

  23. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C. & Ferrin, T. E. (2004). UCSF Chimera--a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25, 1605-1612. https://doi.org/10.1002/jcc.20084

  24. Philoppes, J. N. & Lamie, P. F. (2019). Design and synthesis of new benzoxazole/benzothiazole-phthalimide hybrids as antitumor-apoptotic agents. Bioorganic Chemistry, 89, 102978. https://doi.org/10.1016/j.bioorg.2019.102978

  25. Rivera, G., Ahmad-Shah, S. S., Arrieta-Baez, D., Palos, I., Mongue, A. & Sánchez-Torres, L. E. (2017a). Esters of Quinoxaline 1,4-Di-N-oxide with Cytotoxic Activity on Tumor Cell Lines Based on NCI-60 Panel. Iranian Journal of Pharmaceutical Research, 16, 953-965. https://dx.doi. org/10.22037/ijpr.2017.2065

  26. Rivera, G., Andrade-Ochoa, S., Romero, M. S. O., Palos, I., Monge, A. & Sanchez-Torres, L. E. (2017b). Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study. Anticancer Agents in Medicinal Chemistry, 17, 682-691. https://doi.org/10.2174/187152061666616 0630175927

  27. Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F. & Schroeder, M. (2015). PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Research, 43, W443-447. https://dx.doi.org/10.1093/nar/gkv315

  28. Shiheido, H., Terada, F., Tabata, N., Hayakawa, I., Matsumura, N., Takashima, H., Ogawa, Y., Du, W., Yamada, T., Shoji, M., Sugai, T., Doi, N., Iijima, S., Hattori, Y. & Yanagawa, H. (2012). A phthalimide derivative that inhibits centrosomal clustering is effective on multiple myeloma. PLoS One, 7, e38878. https://doi.org/10.1371/journal.pone.0038878

  29. Siedlecki, P, Garcia Boy, R, Musch, T, Brueckner, B, Suhai, S, Lyko, F. & Zielenkiewicz, P. (2006). Discovery of two novel, small-molecule inhibitors of DNA methylation. Journal of Medicinal Chemistry, 49(2), 678-683. https:// doi.org/10.1021/jm050844z

  30. Sundaresan, L., Kumar, P., Manivannan, J., Balaguru, U. M., Kasiviswanathan, D., Veeriah, V., Anishetty, S. & Chatterjee, S. (2019). Thalidomide and Its Analogs Differentially Target Fibroblast Growth Factor Receptors: Thalidomide Suppresses FGFR Gene Expression while Pomalidomide Dampens FGFR2 Activity. Chemistry Research in Toxicology, 32(4), 589-602. https://doi.org/10.1021/acs. chemrestox.8b00286

  31. Trott, O. & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455-461. https://doi. org/10.1002/jcc.21334

  32. WHO. World Health Organization (2019). Cancer, Available at https://www.who.int/cancer/en/.

  33. Xie, L., Cui, J., Qian, X., Xu, Y., Liu, J. & Xu, R. (2011). 5-Non-amino aromatic substituted naphthalimides as potential anti-tumor agents: synthesis via suzuki reaction, anti-proliferative activity, and DNA-binding behavior. Bioorganic & Medicinal Chemistry, 19, 961-967. https:// doi.org/10.1016/j.bmc.2010.11.055

  34. Yu, N. & Wang, M. (2008). Anticancer drug discovery target ing DNA hyper methylation. Current Medicinal Chemistry, 15, 1350-1375. https://doi. org/10.2174/092986708784567653

  35. Zahran, M. A. H., Abdin, Y. G., Osman, A. M. A., Gamal-Eldeen, A. M., Talaat, R. M. & Pedersen, E. B. (2014). Synthesis and Evaluation of Thalidomide and Phthalimide Esters as Antitumor Agents. Archiv der Pharmazie, 347, 642-649. https://doi.org/10.1002/ardp.201400073




2020     |     www.medigraphic.com